메뉴 건너뛰기




Volumn 32, Issue 6, 2012, Pages 1843-1844

Rituximab in childhood lupus myocarditis

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTINUCLEAR ANTIBODY; CARVEDILOL; CREATININE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; INOTROPIC AGENT; METHYLPREDNISOLONE; PREDNISOLONE; RITUXIMAB; UREA;

EID: 84863858407     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-1881-3     Document Type: Letter
Times cited : (11)

References (17)
  • 2
    • 0342962557 scopus 로고    scopus 로고
    • Systemic lupus erythematosus and the cardiovascular system: The heart
    • Lahita RG (ed) Churchill Livingstone, New York
    • Petri M (1998) Systemic lupus erythematosus and the cardiovascular system: the heart. In: Lahita RG (ed) Systemic lupus erythematosus. Churchill Livingstone, New York
    • (1998) Systemic Lupus Erythematosus
    • Petri, M.1
  • 3
    • 0026695617 scopus 로고
    • Impairement in left ventricular diastolic function in systemic lupus erythematosus
    • Sasson Z, Rasooly Y, Chow CW, Marshall S, Urowitz MB (1992) Impairement in left ventricular diastolic function in systemic lupus erythematosus. Am J Cardiol 69(19):1629-1634
    • (1992) Am J Cardiol , vol.69 , Issue.19 , pp. 1629-1634
    • Sasson, Z.1    Rasooly, Y.2    Chow, C.W.3    Marshall, S.4    Urowitz, M.B.5
  • 4
    • 0035282653 scopus 로고    scopus 로고
    • Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome
    • Roman MJ, Salmon JE, Sobel R, Lokshin M, Sammaritano L, Schwartz JE, Devereux RB (2001) Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome. Am J Cardiol 87:663-666
    • (2001) Am J Cardiol , vol.87 , pp. 663-666
    • Roman, M.J.1    Salmon, J.E.2    Sobel, R.3    Lokshin, M.4    Sammaritano, L.5    Schwartz, J.E.6    Devereux, R.B.7
  • 5
    • 3042686859 scopus 로고    scopus 로고
    • Myocarditis as a prognostic indicator in systemic lupus erythematosus
    • Busteed S, Sparrow P, Molloy C, Molloy MG (2004) Myocarditis as a prognostic indicator in systemic lupus erythematosus. Postgrad Med J 80:366-367
    • (2004) Postgrad Med J , vol.80 , pp. 366-367
    • Busteed, S.1    Sparrow, P.2    Molloy, C.3    Molloy, M.G.4
  • 6
    • 0018125089 scopus 로고
    • The myocarditis of systemic lupus erythematosus: Association with myositis
    • Borenstein DG, Fye WB, Arnett FC, Stevens MB (1978) The myocarditis of systemic lupus erythematosus: association with myositis. Ann Intern Med 89:619-624
    • (1978) Ann Intern Med , vol.89 , pp. 619-624
    • Borenstein, D.G.1    Fye, W.B.2    Arnett, F.C.3    Stevens, M.B.4
  • 7
    • 0021850137 scopus 로고
    • Cardiovascular manifestations of systemic lupus erythematosus: Current perspective
    • Ansari A, Larson PH, Bates HD (1985) Cardiovascular manifestations of systemic lupus erythematosus: current perspective. Prog Cardiovasc Dis 27:421-434
    • (1985) Prog Cardiovasc Dis , vol.27 , pp. 421-434
    • Ansari, A.1    Larson, P.H.2    Bates, H.D.3
  • 9
    • 0032875710 scopus 로고    scopus 로고
    • Dramatic improvement of left ventricular function after cytotoxic therapy in lupus patients with acute cardiomyopathy: Report of 6 cases
    • Naarendorp M, Kerr LD, Khan AS, Ornstein MH (1999) Dramatic improvement of left ventricular function after cytotoxic therapy in lupus patients with acute cardiomyopathy: report of 6 cases. J Rheumatol 26:2257-2260
    • (1999) J Rheumatol , vol.26 , pp. 2257-2260
    • Naarendorp, M.1    Kerr, L.D.2    Khan, A.S.3    Ornstein, M.H.4
  • 10
    • 0344873335 scopus 로고    scopus 로고
    • Intravenous cyclophosphamide improves cardiac dysfunction in lupus myocarditis
    • Chan YK, Li EK, Tam LS, Chow LT, Ng HK (2003) Intravenous cyclophosphamide improves cardiac dysfunction in lupus myocarditis. Scand J Rheumatol 32:306-308
    • (2003) Scand J Rheumatol , vol.32 , pp. 306-308
    • Chan, Y.K.1    Li, E.K.2    Tam, L.S.3    Chow, L.T.4    Ng, H.K.5
  • 11
    • 34347243151 scopus 로고    scopus 로고
    • Intravenous immunoglobulin therapy in severe lupus myocarditis: Good outcome in three patients
    • Micheloud D, Calderón M, Caparrros M, D'Cruz P (2007) Intravenous immunoglobulin therapy in severe lupus myocarditis: good outcome in three patients. Ann Rheum Dis 66:986-987
    • (2007) Ann Rheum Dis , vol.66 , pp. 986-987
    • Micheloud, D.1    Calderón, M.2    Caparrros, M.3    D'Cruz, P.4
  • 12
    • 0032983315 scopus 로고    scopus 로고
    • Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus
    • Sherer Y, Levy Y, Shoenfeld Y (1999) Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus. Clin Rheumatol 18:238-240
    • (1999) Clin Rheumatol , vol.18 , pp. 238-240
    • Sherer, Y.1    Levy, Y.2    Shoenfeld, Y.3
  • 13
    • 21144438589 scopus 로고    scopus 로고
    • Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases
    • Gottenberg J-E, Guillevin L, Lambotte O et al (2005) Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis 64:920-923
    • (2005) Ann Rheum Dis , vol.64 , pp. 920-923
    • Gottenberg, J.-E.1    Guillevin, L.2    Lambotte, O.3
  • 14
    • 47149117833 scopus 로고    scopus 로고
    • Complete remission of lupus nephritis with rituximab and steroids for induction and rituximab alone for maintenance therapy
    • Camous L, Melander C, Vallet M, Squalli T, Knebelmann B, Noël LH, Fakhouri F (2008) Complete remission of lupus nephritis with rituximab and steroids for induction and rituximab alone for maintenance therapy. Am J Kidney Dis 52:346-352
    • (2008) Am J Kidney Dis , vol.52 , pp. 346-352
    • Camous, L.1    Melander, C.2    Vallet, M.3    Squalli, T.4    Knebelmann, B.5    Noël, L.H.6    Fakhouri, F.7
  • 15
    • 28544449032 scopus 로고    scopus 로고
    • B cell depletion in the treatment of patients with systemic lupus erythematosus: A longitudinal analysis of 24 patients
    • (Oxford)
    • Leandro MJ, Cambridge G, Edward JC, Ehrenstein MR, Isenberg DA (2005) B cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients. Rheumatology 44:2542-2545 (Oxford)
    • (2005) Rheumatology , vol.44 , pp. 2542-2545
    • Leandro, M.J.1    Cambridge, G.2    Edward, J.C.3    Ehrenstein, M.R.4    Isenberg, D.A.5
  • 16
    • 84863866520 scopus 로고    scopus 로고
    • Therapy resistant lupus skin disease successfully treated with rituximab
    • features in systemic lupus erythematosus: analysis of 600 patients from a single center. Semin Arthritis Rheum 33 227-230
    • Risselada AP, Kallenberg CGM (2004) Therapy resistant lupus skin disease successfully treated with rituximab. Rheumatology 45:925-926 features in systemic lupus erythematosus: analysis of 600 patients from a single center. Semin Arthritis Rheum 33:227-230
    • (2004) Rheumatology , vol.45 , pp. 925-926
    • Risselada, A.P.1    Kallenberg, C.G.M.2
  • 17
    • 32044431886 scopus 로고    scopus 로고
    • Rituximab treatment for immune thrombocytopenia associated with systemic lupus erythematosus
    • Lehembre S, Macario-Barrel A, Musette P, Carvalho P, Loly P (2006) Rituximab treatment for immune thrombocytopenia associated with systemic lupus erythematosus. Ann Dermatol Venereol 233:53-55
    • (2006) Ann Dermatol Venereol , vol.233 , pp. 53-55
    • Lehembre, S.1    MacArio-Barrel, A.2    Musette, P.3    Carvalho, P.4    Loly, P.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.